The U.S. is gearing up for another wave of COVID-19 infections this fall and winter following a flurry of activity this week that included putting billions of dollars toward COVID-19 vaccines and treatments and setting up new rules for updating shots.
The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week that included putting billions of dollars toward more COVID-19 vaccines and treatments and setting up new rules for how to update the shots.“The speed with which this announcement followed the VRBPAC [Vaccines and Related Biological Products Advisory Committee] meeting suggests the U.S.
Public-health experts say omicron and its family of subvariants, including the currently circulating BA.4 and BA.5, have been behind the increase in infections in different parts of the U.S. ever since the omicron surge in December and January. During Tuesday’s meeting, executives at Moderna MRNA, +4.13%, Pfizer, and Novavax NVAX, +5.46% told the FDA advisors that they could have ready BA.4 boosters by the final three months of the year.